On April 29, 2024, the Food and Drug Administration (FDA) announced a final rule to consider laboratory-developed tests (LDTs) to be...

In just the first few weeks of 2024, two separate cases of allegations of research misconduct have been publicized. In both cases, the...

Featured Excerpt Over the past several years, legislators nationwide have scrutinized Pharmacy Benefit Managers (PBMs) due to various...

It is inevitable that the Biden administration would review and make changes to the Part D drug pricing agenda set forth by the Trump...